Careers
Media
FAQ
NEWS
Contact Us
Patients
NEUROLOGY
CinnoVex
ReciGen
CinnoMer
CinnoTec
ONCOLOGY & HAEMATOLOGY
PegaGen
CinnaPoietin
KidiPeg
GYNECOLOGY & HORMONE
Cinnal-f
CinnaTropin
CinnaFact
RHEUMATOLOGY
CinnoPar
CinnoRA
KidiMab
Healthcare Professionals
NEUROLOGY
CinnoVex
ReciGen
CinnoMer
CinnoTec
ONCOLOGY & HAEMATOLOGY
PegaGen
CinnaPoietin
KidiPeg
GYNECOLOGY & HORMONE
Cinnal-f
CinnaTropin
CinnaFact
RHEUMATOLOGY
CinnoPar
CinnoRA
Capabilities
Our Technology
Business Development
Our Manufacturing Sites
Research and Development
About Us
Presidential Note
About CinnaGen
Mission Statement
Policy
Management Team
Search
Careers
Media
FAQ
NEWS
Contact Us
فا
News
Cinnagen in Duphat
03Mar. 2018
CinnaGen recently participated in Duphat, the biggest pharmaceutical event in the MENA region.
CinnaGen obtained GMP certification from EMA
24Feb. 2018
Iranian biosimilar company CinnaGen obtained GMP certification from EMA
CinnaGen, Exporter of the year
09Mar. 2017
Dr. Hamedifar, a PharmaHero
30Jan 2017
Dr. Hamedifar is selected as PharmaHero by UBC.
CinnaGen ilaç
20Jan 2017
CinnaGen enters Turkey pharmaceutical market.
CinnoVex in medical reference books
18Jan 2017
Razi Research Festival on Medical Sciences
17Jan 2017
Launching the Iranian medicine "CinnoRA", in the presence of Minister of Health
26Oct 2016
Cooperation between CYPRUS and IRAN in health sector
19Sept. 2016
CinnoRA is now available in the market
10Sept. 2016
Liquid CinnoVex is now available in the market
27Aug. 2016
CinnoVex (Interferon beta-1a) has a new formulation in liquid form.
Monthly Arvhive
All News
Oct2016
Sept.2016
Aug.2016
Mar.2018
Mar.2017
Feb.2018
Jan2017
Home
News
Back top Top
